Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on D Mannose. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel CsF catalyzed synthesis ensures high purity alpha anomer. Reduces purification costs for pharmaceutical intermediates manufacturing.
Patent CN103739635B enables high yield purification for PET imaging precursors ensuring supply chain stability and cost efficiency for global pharmaceutical manufacturers.
Patent CN101293889B details a novel glycosylation method for artemisinin. Enhance solubility and reduce toxicity with our scalable pharmaceutical intermediate manufacturing.
Novel patent CN116410244B enables high-yield D-mannose production. Reduces costs and ensures supply continuity for global pharmaceutical intermediate manufacturing partners.
Novel patent CN116410244B details improved D-mannose synthesis yielding 50-60%. Offers cost reduction and supply reliability for PET imaging precursor manufacturing.
Patent CN103739635A reveals a novel recrystallization method for 1,3,4,6-tetra-O-acetyl-beta-D-mannopyranose, significantly boosting yield and purity for reliable 18F-FDG production.